A summary of the osteosarcoma banking efforts: A report from the Children's Oncology Group and the QuadW Foundation

Jason Glover, Mark Krailo, Tanya Tello, Neyssa Marina, Katherine Janeway, Don Barkauskas, Timothy M Fan, Richard Gorlick, Chand Khanna

Research output: Contribution to journalArticle

Abstract

Background: Survival rates of patients with osteosarcoma have remained stagnant over the last thirty years. Better understanding of biology, new therapeutics, and improved biomarkers are needed. The Children's Oncology Group (COG) addressed this need by developing one of the largest osteosarcoma biorepositories ever, containing over 15,000 tumor and tissue samples from over 1,500 patients. Procedure: The biology study P9851 and the banking study AOST06B1 has enrolled 1,787 patients (as of September, 2013). Clinical information was lacking on 510 patients on P9851, who were not enrolled on a concurrent therapeutic trial. The value of these specimens was diminished. The lack of statistical support available for biology projects slowed the analysis of several critical studies. The QuadW Foundation, CureSearch, and the COG formed the Childhood Sarcoma Biostatistics and Annotation Office (CSBAO) to provide the infrastructure and address these needs by linking clinically annotated patient data to archived tissue samples and to develop biostatistical support for childhood sarcoma research. Results: Originally 5.3% of samples from the 510 patients on P9851 not enrolled on a therapeutic study had full clinical annotation. The efforts of the CSBAO have linked clinical annotation to 90.8% of those specimens and provided statistical analyses to several studies that had used COG samples. As a result, 24 biology studies in osteosarcoma have been completed and published in peer-reviewed journals. Conclusions: These samples and in-silico data are available to the research community for basic and translational science projects to improve the biological understanding and treatment of patients affected by osteosarcoma.

Original languageEnglish (US)
Pages (from-to)450-455
Number of pages6
JournalPediatric Blood and Cancer
Volume62
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Osteosarcoma
Biostatistics
Sarcoma
Therapeutics
Research
Computer Simulation
Survival Rate
Biomarkers
Neoplasms

Keywords

  • Banking
  • Biology
  • Bone
  • Osteosarcoma
  • Sarcoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Glover, J., Krailo, M., Tello, T., Marina, N., Janeway, K., Barkauskas, D., ... Khanna, C. (2015). A summary of the osteosarcoma banking efforts: A report from the Children's Oncology Group and the QuadW Foundation. Pediatric Blood and Cancer, 62(3), 450-455. https://doi.org/10.1002/pbc.25346

A summary of the osteosarcoma banking efforts : A report from the Children's Oncology Group and the QuadW Foundation. / Glover, Jason; Krailo, Mark; Tello, Tanya; Marina, Neyssa; Janeway, Katherine; Barkauskas, Don; Fan, Timothy M; Gorlick, Richard; Khanna, Chand.

In: Pediatric Blood and Cancer, Vol. 62, No. 3, 01.03.2015, p. 450-455.

Research output: Contribution to journalArticle

Glover, J, Krailo, M, Tello, T, Marina, N, Janeway, K, Barkauskas, D, Fan, TM, Gorlick, R & Khanna, C 2015, 'A summary of the osteosarcoma banking efforts: A report from the Children's Oncology Group and the QuadW Foundation', Pediatric Blood and Cancer, vol. 62, no. 3, pp. 450-455. https://doi.org/10.1002/pbc.25346
Glover, Jason ; Krailo, Mark ; Tello, Tanya ; Marina, Neyssa ; Janeway, Katherine ; Barkauskas, Don ; Fan, Timothy M ; Gorlick, Richard ; Khanna, Chand. / A summary of the osteosarcoma banking efforts : A report from the Children's Oncology Group and the QuadW Foundation. In: Pediatric Blood and Cancer. 2015 ; Vol. 62, No. 3. pp. 450-455.
@article{6d90d6e67bbf448a8b6b621a6f2d5648,
title = "A summary of the osteosarcoma banking efforts: A report from the Children's Oncology Group and the QuadW Foundation",
abstract = "Background: Survival rates of patients with osteosarcoma have remained stagnant over the last thirty years. Better understanding of biology, new therapeutics, and improved biomarkers are needed. The Children's Oncology Group (COG) addressed this need by developing one of the largest osteosarcoma biorepositories ever, containing over 15,000 tumor and tissue samples from over 1,500 patients. Procedure: The biology study P9851 and the banking study AOST06B1 has enrolled 1,787 patients (as of September, 2013). Clinical information was lacking on 510 patients on P9851, who were not enrolled on a concurrent therapeutic trial. The value of these specimens was diminished. The lack of statistical support available for biology projects slowed the analysis of several critical studies. The QuadW Foundation, CureSearch, and the COG formed the Childhood Sarcoma Biostatistics and Annotation Office (CSBAO) to provide the infrastructure and address these needs by linking clinically annotated patient data to archived tissue samples and to develop biostatistical support for childhood sarcoma research. Results: Originally 5.3{\%} of samples from the 510 patients on P9851 not enrolled on a therapeutic study had full clinical annotation. The efforts of the CSBAO have linked clinical annotation to 90.8{\%} of those specimens and provided statistical analyses to several studies that had used COG samples. As a result, 24 biology studies in osteosarcoma have been completed and published in peer-reviewed journals. Conclusions: These samples and in-silico data are available to the research community for basic and translational science projects to improve the biological understanding and treatment of patients affected by osteosarcoma.",
keywords = "Banking, Biology, Bone, Osteosarcoma, Sarcoma",
author = "Jason Glover and Mark Krailo and Tanya Tello and Neyssa Marina and Katherine Janeway and Don Barkauskas and Fan, {Timothy M} and Richard Gorlick and Chand Khanna",
year = "2015",
month = "3",
day = "1",
doi = "10.1002/pbc.25346",
language = "English (US)",
volume = "62",
pages = "450--455",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - A summary of the osteosarcoma banking efforts

T2 - A report from the Children's Oncology Group and the QuadW Foundation

AU - Glover, Jason

AU - Krailo, Mark

AU - Tello, Tanya

AU - Marina, Neyssa

AU - Janeway, Katherine

AU - Barkauskas, Don

AU - Fan, Timothy M

AU - Gorlick, Richard

AU - Khanna, Chand

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background: Survival rates of patients with osteosarcoma have remained stagnant over the last thirty years. Better understanding of biology, new therapeutics, and improved biomarkers are needed. The Children's Oncology Group (COG) addressed this need by developing one of the largest osteosarcoma biorepositories ever, containing over 15,000 tumor and tissue samples from over 1,500 patients. Procedure: The biology study P9851 and the banking study AOST06B1 has enrolled 1,787 patients (as of September, 2013). Clinical information was lacking on 510 patients on P9851, who were not enrolled on a concurrent therapeutic trial. The value of these specimens was diminished. The lack of statistical support available for biology projects slowed the analysis of several critical studies. The QuadW Foundation, CureSearch, and the COG formed the Childhood Sarcoma Biostatistics and Annotation Office (CSBAO) to provide the infrastructure and address these needs by linking clinically annotated patient data to archived tissue samples and to develop biostatistical support for childhood sarcoma research. Results: Originally 5.3% of samples from the 510 patients on P9851 not enrolled on a therapeutic study had full clinical annotation. The efforts of the CSBAO have linked clinical annotation to 90.8% of those specimens and provided statistical analyses to several studies that had used COG samples. As a result, 24 biology studies in osteosarcoma have been completed and published in peer-reviewed journals. Conclusions: These samples and in-silico data are available to the research community for basic and translational science projects to improve the biological understanding and treatment of patients affected by osteosarcoma.

AB - Background: Survival rates of patients with osteosarcoma have remained stagnant over the last thirty years. Better understanding of biology, new therapeutics, and improved biomarkers are needed. The Children's Oncology Group (COG) addressed this need by developing one of the largest osteosarcoma biorepositories ever, containing over 15,000 tumor and tissue samples from over 1,500 patients. Procedure: The biology study P9851 and the banking study AOST06B1 has enrolled 1,787 patients (as of September, 2013). Clinical information was lacking on 510 patients on P9851, who were not enrolled on a concurrent therapeutic trial. The value of these specimens was diminished. The lack of statistical support available for biology projects slowed the analysis of several critical studies. The QuadW Foundation, CureSearch, and the COG formed the Childhood Sarcoma Biostatistics and Annotation Office (CSBAO) to provide the infrastructure and address these needs by linking clinically annotated patient data to archived tissue samples and to develop biostatistical support for childhood sarcoma research. Results: Originally 5.3% of samples from the 510 patients on P9851 not enrolled on a therapeutic study had full clinical annotation. The efforts of the CSBAO have linked clinical annotation to 90.8% of those specimens and provided statistical analyses to several studies that had used COG samples. As a result, 24 biology studies in osteosarcoma have been completed and published in peer-reviewed journals. Conclusions: These samples and in-silico data are available to the research community for basic and translational science projects to improve the biological understanding and treatment of patients affected by osteosarcoma.

KW - Banking

KW - Biology

KW - Bone

KW - Osteosarcoma

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84921437012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921437012&partnerID=8YFLogxK

U2 - 10.1002/pbc.25346

DO - 10.1002/pbc.25346

M3 - Article

C2 - 25611047

AN - SCOPUS:84921437012

VL - 62

SP - 450

EP - 455

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 3

ER -